John Jeans is a Non-Executive Director, Chair and mentor to innovative companies. He currently chairs 52 North Health and HistoIndex and has previously led organisations such as EM Imaging, the Digital Health & Care Innovation Centre, Imanova and the UK BioCentre. His board experience further includes senior roles at Renishaw, Alliance Medical and Prometic Life Sciences, Prometic Pharma SMT, Karoo CGT and Myconostica.

He brings extensive international experience through his work as Co-Chair of Singapore Government's Diagnostics Hub and Digital Health Accelerator, and his past advisory roles within the country’s Manufacturing and Engineering and Health and Biomedical Sciences ecosystems. In the UK, Dr. Jeans has held influential national positions, including Deputy Chief Executive of the Medical Research Council and Chair of the MRC Technology (LifeArc) Trustee Board. Appointed by the Prime Minister as the UK’s Life Science Champion for Medical Technology, he has contributed to advisory panels for the MRC, EPSRC, NIHR, HDR UK, NCUB, NPL, HDRUK and the Wellcome Trust, and played a foundational role in establishing the Francis Crick Institute.

Across a 35-year industry career, John Jeans held senior international leadership roles at Smith & Nephew, Bristol Myers Squibb, Johnson & Johnson, and GE Healthcare, where he headed the commercial function of GE’s Life Sciences business. His expertise spans medical devices, pharmaceuticals, in-vivo and in-vitro diagnostics, shaping advancements across research, development, manufacturing and commercialisation. In addition to his professional work, he supports several charities, including the Africa Research Excellence Fund.

John is a Fellow of the Royal College of Art and Cardiff University, where he formerly served as Chair of Council and a Director of the University Employers Association. His significant contributions to healthcare and science have been recognised with the award of a CBE in 2012 and Singapore’s Public Service Medal in 2021.